Crake Asset Management LLP Has $8.79 Million Stock Holdings in Humana Inc. $HUM

Crake Asset Management LLP cut its stake in shares of Humana Inc. (NYSE:HUM) by 56.0% during the fourth quarter, Holdings Channel reports. The firm owned 34,310 shares of the insurance provider’s stock after selling 43,640 shares during the quarter. Humana makes up approximately 0.3% of Crake Asset Management LLP’s portfolio, making the stock its 15th largest holding. Crake Asset Management LLP’s holdings in Humana were worth $8,788,000 at the end of the most recent quarter.

Several other large investors have also recently bought and sold shares of HUM. Montag A & Associates Inc. raised its position in Humana by 1,880.0% during the fourth quarter. Montag A & Associates Inc. now owns 99 shares of the insurance provider’s stock valued at $25,000 after buying an additional 94 shares during the period. CoreCap Advisors LLC raised its position in Humana by 54.4% during the fourth quarter. CoreCap Advisors LLC now owns 105 shares of the insurance provider’s stock valued at $27,000 after buying an additional 37 shares during the period. Fideuram Asset Management Ireland dac acquired a new position in Humana during the fourth quarter valued at $27,000. Rosenberg Matthew Hamilton raised its position in Humana by 136.0% during the fourth quarter. Rosenberg Matthew Hamilton now owns 118 shares of the insurance provider’s stock valued at $30,000 after buying an additional 68 shares during the period. Finally, Larson Financial Group LLC raised its position in Humana by 114.1% during the third quarter. Larson Financial Group LLC now owns 152 shares of the insurance provider’s stock valued at $40,000 after buying an additional 81 shares during the period. 92.38% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several research analysts recently weighed in on the company. Needham & Company LLC assumed coverage on Humana in a research report on Wednesday, May 20th. They set a “buy” rating on the stock. The Goldman Sachs Group upped their price target on Humana from $158.00 to $195.00 and gave the company a “sell” rating in a research report on Thursday, April 30th. Deutsche Bank Aktiengesellschaft lowered Humana from a “buy” rating to a “hold” rating in a research report on Wednesday, May 20th. Truist Financial upped their price target on Humana from $220.00 to $270.00 and gave the company a “hold” rating in a research report on Thursday, April 30th. Finally, UBS Group upped their price target on Humana from $262.00 to $320.00 and gave the company a “neutral” rating in a research report on Friday, May 22nd. Nine research analysts have rated the stock with a Buy rating, fifteen have issued a Hold rating and four have assigned a Sell rating to the company. According to data from MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $270.48.

Humana Stock Performance

HUM opened at $305.97 on Friday. The company has a market cap of $36.73 billion, a PE ratio of 32.72, a price-to-earnings-growth ratio of 2.21 and a beta of 0.68. The stock has a 50-day moving average of $231.96 and a 200-day moving average of $229.04. Humana Inc. has a 52-week low of $163.11 and a 52-week high of $315.66. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.77 and a current ratio of 1.77.

Humana (NYSE:HUM) last released its quarterly earnings results on Wednesday, April 29th. The insurance provider reported $10.31 earnings per share (EPS) for the quarter, topping the consensus estimate of $9.97 by $0.34. The company had revenue of $39.65 billion during the quarter, compared to the consensus estimate of $39.37 billion. Humana had a return on equity of 10.45% and a net margin of 0.82%.The firm’s revenue was up 23.5% on a year-over-year basis. During the same quarter in the prior year, the company posted $11.58 EPS. Humana has set its FY 2026 guidance at 9.000- EPS. As a group, equities research analysts forecast that Humana Inc. will post 9.01 earnings per share for the current fiscal year.

Humana Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be paid a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a dividend yield of 1.2%. The ex-dividend date is Friday, June 26th. Humana’s dividend payout ratio is 37.86%.

Humana Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.